Delivery Order SPE2DB22D1106-SPE2DB25FEZR7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,119.21 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This is a firm fixed-price, competitively awarded delivery order with an ultimate completion date of July 22, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,812.82 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 8 mg tablets (30-count packages). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement and carries an ultimate completion date of July 22, 2025. The order will be fulfilled from AmerisourceBergen's operations in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $19,014.45 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive award, which carries no set-aside designation, utilizes firm fixed price pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $1,911.52 to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count units) on July 21, 2025, with completion scheduled for July 22, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ondansetron ODT 8 mg tablets (30-count) valued at $2,744.16, with an ultimate completion date of July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The place of performance is the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) under a firm fixed-price contract valued at $3,343.37. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a competitively awarded, non-set-aside order with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract valued at $4,095.39 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,269.75 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, Corporate Office Division, for the supply of 4565536168 Ondansetron ODT 4 mg Tablets in 30-count packages. This order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued up to $999,999,999 through December 2025, for the provision of a comprehensive range of pharmaceutical and medical supplies to support...
- The Defense Logistics Agency awarded a delivery order valued at $14,466.96 to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Ondansetron HCL 4 mg tablets in quantities of 30. The contract represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, with an ultimate completion date of July 21, 2025. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $13.45K to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99M ceiling value and extends...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FEZR7Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,983.03 to AmerisourceBergen Drug Corp for the supply of Ondansetron ODT 4 mg tablets (30-count packages). This firm fixed-price delivery order, which was competitively awarded with no set-aside designation, is scheduled for completion by July 28, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime vendor agreement running through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal healthcare vendor, serves military and veteran healthcare systems through its comprehensive pharmaceutical supply portfolio. The parent IDC vehicle enables the company to supply an extensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support defense healthcare programs globally. This particular delivery order for ondansetron, an anti-nausea medication commonly used in military medical settings, exemplifies the routine pharmaceutical procurement conducted through the DLA's broader prime vendor contracting strategy.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 7/25/25 |